Can weight loss drugs curb alcohol addictions? This Louisiana doctor is keeping an eye on new findings and emerging research.

Cancer researchers found that patients on GLP-1s had significant risk reductions for 10 of 13 obesity-associated cancers.

Eli Lilly's popular obesity drug Zepbound can now be covered by government-backed Medicare drug plans, CNBC reported on ...

The governor also said she would work with other states to leverage their combined purchasing power to reduce the cost of the ...

An international commission made the case for focusing on body fat quantity and the illnesses people experience.

Metabolic medicines dominated life sciences headlines in 2024, a trend expected to continue into the new year. Other things ...

Danish drugmaker Novo Nordisk and U.S. tech firm Valo Health said on Wednesday they were expanding their 2023 agreement to ...

Variant Bio, a small biotech company based in Seattle, is using genetic information from Indigenous people to develop drugs for obesity and diabetes ... Islanders in New Zealand to talk about ...

Based in New York, Metsera (MTSR) is developing oral and injectable medications for the treatment of obesity and related conditions. Its lead drug candidate, MTE-097i, is an ultra-long-acting GLP ...

A systematic review of randomized controlled trials (RCTs) assessed the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and co-agonists for obesity in adults without ...

A coalition of obesity-related patient advocacy groups is calling on the incoming Trump administration to finalize a proposal ...